Get started
Author

Toshie Iijima

Observed names: Iijima Toshie, Iijima, Toshie, T. Iijima, TOSHIE IIJIMA
ORCID: 0000-0002-4613-3744
Observed ORCID: 0000-0002-4613-3744
OpenAlex ID: A5038865449
Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease
2018 · Masanori Shimizu, Kunihiro Suzuki, et al. · Diabetes Obesity and Metabolism · 409
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes
2016 · Teruo Jojima, Takanori Tomotsune, et al. · Diabetology & Metabolic Syndrome · 206
PDF
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
2019 · Teruo Jojima, Sho Wakamatsu, et al. · International Journal of Molecular Sciences · 126
PDF
Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice
2017 · Teruo Jojima, Kohsuke Uchida, et al. · Atherosclerosis · 109
Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase‐4 in patients with type 2 diabetes and non‐alcoholic fatty liver disease
2019 · Yoshimasa Aso, Kanako Kato, et al. · International Journal of Clinical Practice · 100
PDF
Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes
2015 · Yoshimasa Aso, Maiko Fukushima, et al. · Diabetes Research and Clinical Practice · 42
Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis
2020 · Shintaro Sakurai, Teruo Jojima, et al. · Journal of Diabetes and its Complications · 40
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial
2022 · Atsushi Tanaka, Masataka Sata, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 33
PDF
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+CXCR4+ cells in patients with type 2 diabetes
2015 · Yoshimasa Aso, T. Jojima, et al. · Endocrine · 33
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report
2020 · Teruo Jojima, Takahiko Kogai, et al. · European Journal of Endocrinology · 31
Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol
2021 · Teruo Jojima, Shintaro Sakurai, et al. · International Journal of Cardiology · 29
The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes
2013 · Yoshimasa Aso, Tomoko Terasawa, et al. · Translational research · 26
Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients
2011 · Yoshiaki Kawagoe, Yoshiyuki Hattori, et al. · Endocrine Journal · 26
PDF
Circulating CD4+PD-1+ and CD8+PD-1+ T cells are profoundly decreased at the onset of fulminant type 1 diabetes and are restored by treatment, contrasting with CD4+CD25+FoxP3+ regulatory T cells
2017 · Toshie Iijima, Kanako Kato, et al. · Diabetes Research and Clinical Practice · 18
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor
2023 · Sho Wakamatsu, Teruo Jojima, et al. · Journal of Diabetes and its Complications · 14
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease
2021 · Yoshimasa Aso, Masaaki Sagara, et al. · Journal of Investigative Medicine · 14
Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis
2021 · Masaaki Sagara, Toshie Iijima, et al. · Journal of Diabetes and its Complications · 13
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report
2019 · Tomohisa Kunii, Toshie Iijima, et al. · Journal of Medical Case Reports · 13
PDF
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet–Fed Mice
2022 · Haruka Kishi, Isao Usui, et al. · International Journal of Molecular Sciences · 12
PDF
Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes
2020 · Yoshimasa Aso, Masato Kase, et al. · The American Journal of the Medical Sciences · 9
Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial
2023 · Yuichi Saito, Atsushi Tanaka, et al. · Hypertension Research · 8
PDF
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes
2022 · Masato Kase, Toshie Iijima, et al. · Diabetology International · 8
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes
2024 · Yoshimasa Aso, Toshie Iijima, et al. · Postgraduate Medicine · 7
No Negative Impact of a National State of Emergency by COVID-19 Outbreak on Hemoglobin A1c Levels in Patients With Type 2 Diabetes Living in Semi-Rural Japan
2021 · Yoshimasa Aso, Toshie Iijima, et al. · The American Journal of the Medical Sciences · 7
PDF
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
2023 · Shinji Kishimoto, Yukihito Higashi, et al. · Cardiovascular Diabetology · 6
PDF
Works count: 53
Citation count: 1,389
H-index: 14
I10-index: 19
Year
Topic
Type